Centene Corporation

93.32+0.2700+0.29%Vol 1.83M1Y Perf 39.30%
Aug 8th, 2022 16:03 DELAYED
BID91.49 ASK93.54
Open93.25 Previous Close93.32
Pre-Market- After-Market92.25
 - -  -1.07 -1.15%
Target Price
100.31 
Analyst Rating
Strong Buy 1.43
Potential %
7.49 
Finscreener Ranking
★★     44.87
Insiders Trans % 3/6/12 mo.
-100/-25/-80 
Value Ranking
     40.14
Insiders Value % 3/6/12 mo.
-100/-17/-82 
Growth Ranking
★★+     48.70
Insiders Shares Cnt. % 3/6/12 mo.
-100/-16/-83 
Income Ranking
 —    -
Price Range Ratio 52W %
96.39 
Earnings Rating
Strong Buy
Market Cap54.13B 
Earnings Date
26th Jul 2022
Alpha0.01 Standard Deviation0.09
Beta0.48 

Today's Price Range

92.9594.04

52W Range

59.6794.58

5 Year PE Ratio Range

14.0032.40

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
0.01%
1 Month
6.03%
3 Months
17.84%
6 Months
8.57%
1 Year
39.30%
3 Years
91.62%
5 Years
125.60%
10 Years
826.71%

TickerPriceChg.Chg.%
CNC93.320.27000.29
AAPL164.87-0.4800-0.29
GOOG118.14-0.0800-0.07
MSFT280.32-2.5900-0.92
XOM88.950.50000.57
WFC43.19-0.5700-1.30
JNJ170.20-0.9100-0.53
FB196.640.99000.51
GE75.180.82001.10
JPM114.35-1.4100-1.22
 
ProfitabilityValueIndustryS&P 500US Markets
4.70
2.00
3.10
2.30
1.95
RevenueValueIndustryS&P 500US Markets
102.16B
174.67
24.36
24.58
Earnings HistoryEstimateReportedSurprise %
Q02 20221.731.772.31
Q01 20221.681.838.93
Q04 20210.981.013.06
Q03 20211.291.26-2.33
Q02 20211.411.25-11.35
Q01 20211.651.63-1.21
Q04 20200.450.462.22
Q03 20200.961.2631.25
Earnings Per EndEstimateRevision %Trend
6/2022 QR1.6916.55Positive
9/2022 QR1.24-4.62Negative
12/2022 FY5.644.06Positive
12/2023 FY6.28-0.63Negative
Next Report Date-
Estimated EPS Next Report1.69
Estimates Count7
EPS Growth Next 5 Years %13.70
Volume Overview
Volume1.83M
Shares Outstanding580.07K
Shares Float518.48M
Trades Count25.15K
Dollar Volume170.73M
Avg. Volume2.60M
Avg. Weekly Volume2.31M
Avg. Monthly Volume2.77M
Avg. Quarterly Volume2.71M

Centene Corporation (NYSE: CNC) stock closed at 93.32 per share at the end of the most recent trading day (a 0.29% change compared to the prior day closing price) with a volume of 1.83M shares and market capitalization of 54.13B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 71300 people. Centene Corporation CEO is Michael F. Neidorff.

The one-year performance of Centene Corporation stock is 39.3%, while year-to-date (YTD) performance is 13.25%. CNC stock has a five-year performance of 125.6%. Its 52-week range is between 59.67 and 94.58, which gives CNC stock a 52-week price range ratio of 96.39%

Centene Corporation currently has a PE ratio of 35.60, a price-to-book (PB) ratio of 1.93, a price-to-sale (PS) ratio of 0.51, a price to cashflow ratio of 10.00, a PEG ratio of 2.32, a ROA of 2.01%, a ROC of 4.19% and a ROE of 5.75%. The company’s profit margin is 1.95%, its EBITDA margin is 3.10%, and its revenue ttm is $102.16 Billion , which makes it $174.66 revenue per share.

Of the last four earnings reports from Centene Corporation, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.69 for the next earnings report. Centene Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for Centene Corporation is Strong Buy (1.43), with a target price of $100.31, which is +7.49% compared to the current price. The earnings rating for Centene Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Centene Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Centene Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 7.50, ATR14 : 2.19, CCI20 : 71.32, Chaikin Money Flow : 0.14, MACD : 2.13, Money Flow Index : 66.22, ROC : 3.21, RSI : 72.12, STOCH (14,3) : 76.71, STOCH RSI : 0.63, UO : 56.61, Williams %R : -23.29), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Centene Corporation in the last 12-months were: Brent D. Layton (Sold 4 000 shares of value $282 524 ), Brent Layton (Sold 8 000 shares of value $565 048 ), Christopher A. Koster (Sold 28 600 shares of value $2 006 862 ), Christopher J. Coughlin (Buy at a value of $976 440), Colin A. Toney (Sold 2 807 shares of value $232 813 ), Colin Toney (Sold 2 807 shares of value $232 813 ), David P. Thomas (Sold 4 000 shares of value $310 440 ), H. James Dallas (Buy at a value of $250 564), Katie Casso (Sold 8 000 shares of value $633 520 ), Katie N. Casso (Sold 8 000 shares of value $633 520 ), Kenneth A. Burdick (Sold 180 790 shares of value $13 425 000 ), Lori J. Robinson (Sold 1 200 shares of value $111 324 ), Mark J. Brooks (Sold 14 760 shares of value $1 109 250 ), Michael F. Neidorff (Sold 90 000 shares of value $6 789 120 ), Orlando Ayala (Sold 8 430 shares of value $591 533 ), Richard A. Gephardt (Sold 41 520 shares of value $3 144 089 ), Shannon Bagley (Sold 17 000 shares of value $1 477 810 ), Theodore R. Samuels (Buy at a value of $507 494)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
11 (73.33 %)
9 (69.23 %)
9 (75.00 %)
Moderate Buy
1 (6.67 %)
1 (7.69 %)
1 (8.33 %)
Hold
3 (20.00 %)
3 (23.08 %)
2 (16.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.43
Strong Buy
1.50
Strong Buy
1.38

Centene Corporation

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. After acquiring WellCare in early 2020, Centene now serves 21 million medical members, mostly in Medicaid (14 million), Medicare Advantage (1 million total), the individual exchanges (2 million), and other plans (4 million), including Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

CEO: Michael F. Neidorff

Telephone: +1 314 725-4477

Address: 7700 Forsyth Boulevard, St. Louis 63105, MO, US

Number of employees: 71 300

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

59%41%

Bearish Bullish

58%42%

Bearish Bullish

60%40%

TipRanks News for CNC

Wed, 27 Jul 2022 12:45 GMT Analysts Are Bullish on Top Healthcare Stocks: Centene (CNC), Replimune Group (REPL)

- TipRanks. All rights reserved.

Wed, 22 Jun 2022 13:25 GMT Analysts Offer Insights on Healthcare Companies: Centene (CNC), Ionis Pharmaceuticals (IONS) and Intellia Therapeutics (NTLA)

- TipRanks. All rights reserved.

Wed, 22 Jun 2022 03:55 GMT Centene (CNC) Receives a Hold from Mizuho Securities

- TipRanks. All rights reserved.

Thu, 28 Apr 2022 03:56 GMT Centene (CNC) Gets a Hold Rating from Mizuho Securities

- TipRanks. All rights reserved.

Wed, 27 Apr 2022 16:37 GMT Centene (CNC) Receives a Buy from Morgan Stanley

- TipRanks. All rights reserved.

Wed, 27 Apr 2022 04:55 GMT Centene (CNC) Receives a Buy from Deutsche Bank

- TipRanks. All rights reserved.

News

Stocktwits